Abstract
Purpose
To present the clinical and laboratory characteristics, as well as the management, of patients with primary peritoneal serous papillary carcinoma (PPSPC).
Methods
This is a retrospective study of 19 patients with PPSPC who underwent debulking surgery followed by first line chemotherapy and were managed in Metaxa Memorial Cancer Hospital between January 2002 and December 2017.
Results
The median age of the patients was found to be 66 years (range 44–76 years). Clinical presentation of PPSPC included abdominal distention and pain, constipation, as well as loss of appetite and weight gain. Two of the patients did not mention any symptomatology and the disease was suspected by an abnormal cervical smear and elevated CA125 levels respectively. Biomarkers measurement during the initial management of the patients revealed abnormal values of CA125 for all the participants (median value 565 U/ml). Human epididymis secretory protein 4 (HE4) and ratios of blood count were also measured. Perioperative Peritoneal Cancer Index ranged from 6 to 20. Optimal debulking was achieved in 5 cases. All patients were staged as IIIC and IVA PPSPC and received standard chemotherapy with paclitaxel and carboplatin, whereas bevacizumab was added in the 5 most recent cases. Median overall survival was 29 months.
Conclusion
PPSPC is a rare malignancy, the management of which should take place in tertiary oncology centers.
Similar content being viewed by others
References
REFERENCES
Swerdlow M (1959) Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary. Case report. Am J Obstet Gynecol. https://doi.org/10.1016/0002-9378(59)90287-X
Moss EL, Evans T, Pearmain P et al (2015) Should all cases of high-grade serous ovarian, tubal, and primary peritoneal carcinomas be reclassified as tubo-ovarian serous carcinoma? Int J Gynecol Cancer. https://doi.org/10.1097/IGC.0000000000000477
Liao CI, Chow S, Chen L et al (2018) Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US. Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2018.01.030
Bloss JD, Liao SY, Buller RE et al (1993) Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. https://doi.org/10.1006/gyno.1993.1223
Eltabbakh HG, Piver MS (1998) Extraovarian primary peritoneal carcinoma. Cancer Netw Oncol (Williston Park) 12(6):813–819 (discussion 820, 825–6)
Crum CP, Drapkin R, Miron A et al (2007) The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19(1):3–9
Nik NN, Vang R, Shih I-M, Kurman RJ (2013) Origin and pathogenesis of pelvic (Ovarian, Tubal, and Primary Peritoneal) serous carcinoma. Annu Rev Pathol Mech Dis. https://doi.org/10.1146/annurev-pathol-020712-163949
Seidman JD, Zhao P, Yemelyanova A (2011) “Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer. Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2010.11.020
Suh-Burgmann E, Powell CB (2007) Cytoreductive surgery for gynecologic malignancies-new standards of care. Surg Oncol Clin N Am 16(3):667–682 (x–xi)
Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655
Zhu Y, Zhou S, Liu Y et al (2018) Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review. BMC Cancer. https://doi.org/10.1186/s12885-018-4318-5
Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374
González-Moreno S, Kusamura S, Baratti D, Deraco M (2008) Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy. J Surg Oncol 98(4):237–241. https://doi.org/10.1002/jso.21072
Aletti GD, Dowdy SC, Podratz KC, Cliby WA (2007) Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 197:676.e1–7. https://doi.org/10.1016/j.ajog.2007.10.495
Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. https://doi.org/10.1016/j.ejca.2008.10.026
Aletti GD, Dowdy SC, Gostout BS et al (2006) Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. https://doi.org/10.1097/01.AOG.0000192407.04428.bb
Wimberger P, Lehmann N, Kimmig R et al (2007) Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVA). Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2007.02.026
Chi DS, Eisenhauer EL, Lang J et al (2006) What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2006.03.051
Iavazzo C, Gkegkes ID, Vrachnis N (2016) Primary peritoneal cancer in BRCA carriers after prophylactic bilateral salpingo-oophorectomy. J Turkish Ger Gynecol Assoc. https://doi.org/10.5152/jtgga.2016.15223
Sørensen RD, Schnack TH, Karlsen MA (2015) Høgdall CK Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities—a systematic review. Gynecol Oncol 136(3):571–581. https://doi.org/10.1016/j.ygyno.2015.01.534
Neuhausen SL et al (2017) Primary peritoneal serous carcinoma in men: a rare and Non-BRCA-associated Entity. Anticancer Res. https://doi.org/10.21873/anticanres.11662
Hata J, Araki A, Morimoto T et al (2004) Extraovarian primary peritoneal carcinoma in a child. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.10236
Steinhagen PR, Sehouli J (2011) The involvement of retroperitoneal lymph nodes in primary serous-papillary peritoneal carcinoma. A systematic review of the literature. Anticancer Res 31(4):1387–1394
Sakakibara Y, Endo S, Yoshida Y et al (2011) A case of serous surface papillary carcinoma of the peritoneum metastatic to the brain. No Shinkei Geka 39(6):607–610
Recine MA, Deavers MT, Middleton LP et al (2004) Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. https://doi.org/10.1097/00000478-200412000-00015
Nakao M, Oguri T, Maeno K et al (2009) Endobronchial metastasis from primary papillary serous carcinoma of the peritoneum. Intern Med. https://doi.org/10.2169/internalmedicine.48.2140
Yuan J, He L, Han B, Li Y (2017) Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review. World J Surg Oncol. https://doi.org/10.1186/s12957-017-1134-3
Chiou SY, Sheu MH, Wang JH, Chang CY (2003) Peritoneal serous papillary carcinoma: a reappraisal of CT imaging features and literature review. Abdom Imaging 28(6):815–819
Furukawa T, Ueda J, Takahashi S et al (1999) Peritoneal serous papillary carcinoma: Radiological appearance. Abdom Imaging. https://doi.org/10.1007/s002619900446
Piek JM, Kenemans P, Verheijen RH (2004) Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am J Obstet Gynecol. https://doi.org/10.1016/j.ajog.2004.02.067
Iavazzo C, Vorgias G, Katsoulis M et al (2008) Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-008-0678-4
Harter P, Sehouli J, Lorusso D et al (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. https://doi.org/10.1056/NEJMoa1808424
Unal OU, Oztop I, Yazici O et al (2014) Treatment and prognostic factors in primary peritoneal carcinoma: a multicenter study of the anatolian society of medical oncology (ASMO). Oncol Res Treat. https://doi.org/10.1159/000362857
Musella A, Vertechy L, Romito A et al (2016) Bevacizumab in ovarian cancer: state of the art and unanswered questions. Chemotherapy. https://doi.org/10.1159/000448942
Aghajanian C, Blank SV, Goff BA et al (2012) OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. J Clin Oncol. https://doi.org/10.1200/JCO.2012.42.0505
Moore K, Colombo N, Scambia G et al (2019) Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. Obstet Gynecol Surv N Engl J Med 379(26):2495–2505. https://doi.org/10.1056/NEJMoa1810858
Ceresoli M, Verrengia A, Montori G et al (2018) Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study. J Gynecol Oncol. https://doi.org/10.3802/jgo.2018.29.e53
Van Driel WJ, Koole SN, Sikorska K et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. Obstet Gynecol Surv N Engl J Med 378(3):230–240. https://doi.org/10.1056/NEJMoa1708618
Author information
Authors and Affiliations
Contributions
NB: data collection, data analysis, manuscript writing, EV: data collection, manuscript writing, manuscript editing, GV: project development, data analysis, NK: project development, validation, CI: project development, data analysis, manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
We declare that we do not have any conflict of interest.
Informed consent
Informed consent was obtained from all alive individual participants or, in case of deceased patients, from their next of kin.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Blontzos, N., Vafias, E., Vorgias, G. et al. Primary peritoneal serous papillary carcinoma: a case series. Arch Gynecol Obstet 300, 1023–1028 (2019). https://doi.org/10.1007/s00404-019-05280-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-019-05280-z